Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report.
about
The status of pharmacotherapy for autism spectrum disordersPharmacotherapy to control behavioral symptoms in children with autismA heterogeneity-based genome search meta-analysis for autism-spectrum disordersUse of venlafaxine in children and adolescents: a review of current literature.Pharmacotherapeutic management of autism.Autism spectrum disorders: emerging pharmacotherapy.Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.Treatment of inattention, overactivity, and impulsiveness in autism spectrum disordersTreatment of comorbid anxiety and autism spectrum disordersTreatment of Autism Spectrum Disorder in Children and Adolescents.Recent advances in the pharmacotherapy of autism.Pupillometry reveals a mechanism for the Autism Spectrum Disorder (ASD) advantage in visual tasks.The Mechanisms Underlying the ASD Advantage in Visual Search.Treatment of cataplexy in a three-year-old using venlafaxine.Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).Trends, correlates, and disease patterns of antidepressant use among children and adolescents in Taiwan.
P2860
Q28239931-962AEFF7-12C6-4B4E-A768-D8D7990B3CF9Q28265801-EEB262EF-63B1-41C2-89F4-C50EEE644AF5Q28274390-9081CF96-08EE-46ED-BD59-3BBB39590C24Q34093730-6542BBF5-A629-441E-BD9D-551E885BAA39Q34240955-80A340AC-79B8-4EFF-8960-B9E710504500Q36219642-6908F4CA-A4A7-4256-91FD-DF88688B7D80Q36258557-83125BC4-30E9-4B3E-9C17-719B315085D2Q36443014-F4DCB4B4-1816-450F-B9AD-CEEEDB562C27Q37248753-EEBB68E9-36D6-4B5A-A221-3AD243B65603Q37257081-75E6FCB4-F5AF-4D6F-A247-BD8A733EA8CCQ37299857-A730087D-86DD-4E74-858D-5C12B8F84494Q37610236-A3D6E037-2419-4F0B-AF16-A419A8D9DFBDQ37623664-51579D14-E2F8-4CCB-8A86-02FAEAA72761Q37685954-2C8BC0B0-02CD-4902-B1DC-542200A21D05Q42874005-7BCAF18C-B966-4A7D-84AB-285180FD5BCFQ43131165-AB709A4B-58A6-4AED-8232-253D02B94172Q48638481-29A1310A-25E9-4DED-9B55-375D5E6E3272
P2860
Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Venlafaxine in children, adole ...... retrospective clinical report.
@ast
Venlafaxine in children, adole ...... retrospective clinical report.
@en
type
label
Venlafaxine in children, adole ...... retrospective clinical report.
@ast
Venlafaxine in children, adole ...... retrospective clinical report.
@en
prefLabel
Venlafaxine in children, adole ...... retrospective clinical report.
@ast
Venlafaxine in children, adole ...... retrospective clinical report.
@en
P2093
P2860
P1476
Venlafaxine in children, adole ...... retrospective clinical report.
@en
P2093
C Cartwright
D Reichman
E Hollander
P2860
P304
P356
10.1177/088307380001500214
P577
2000-02-01T00:00:00Z